Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TGM2 | P21980 | 7/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | F13A1 | P00488 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TGM1 | P22735 | 1/20 | 0.42 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 3/20 | 0.40 |
| ▸ | MMP2 | P08253 | 3/20 | 0.40 |
| ▸ | MMP9 | P14780 | 3/20 | 0.40 |
| ▸ | NMT1 | P30419 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14301433 | 0.84 | RAB9A (0.52) | ALDH1A1TGM2MAOBF13A1LMNA | |
| Acrylic Acid SCHEMBL28690059 | 0.82 | TGM2 (0.55) | ALDH1A1TGM2F13A1LMNATGM1 | |
| SCHEMBL5082916 | 0.82 | SMN1; SMN2 (0.65) | TGM2MAOBTSHR | |
| SCHEMBL15743566 | 0.81 | PEPD (0.57) | ALDH1A1TGM2MAOBF13A1LMNA | |
| SCHEMBL2056453 | 0.81 | SMN1; SMN2 (0.59) | ALDH1A1LMNATSHRTDP1 | |
| SCHEMBL10778839 | 0.81 | SMN1; SMN2 (0.52) | MAOBTSHRTDP1NMT1 | |
| SCHEMBL13112978 | 0.80 | POLB (0.46) | ALDH1A1MAOB | |
| Hydrochloric Acid SCHEMBL11408619 | 0.80 | RAD51 (0.55) | ALDH1A1MAOBLMNARAD51MMP1 | |
| SCHEMBL380230 | 0.80 | ALDH1A1 (0.52) | ALDH1A1TGM2TDP1RAD51MMP1 | |
| SCHEMBL26417175 | 0.79 | MEN1 (0.57) | LMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265325-A1 | LAMINATE, RELEASE AGENT COMPOSITION, AND METHOD FOR MANUFACTURING PROCESSED SEMICONDUCTOR SUBSTRATE | NISSAN CHEMICAL CORPORATION (JP) | 2023-08-24 | — | — | US | disclosed |
| EP-4166324-A1 | LAMINATE, RELEASE AGENT COMPOSITION, AND METHOD FOR MANUFACTURING PROCESSED SEMICONDUCTOR SUBSTRATE | Nissan Chemical Corporation (JP) | 2023-04-19 | — | — | EP | disclosed |
| CN-108287382-B | Light filter | 三星显示有限公司 | 2021-10-26 | — | — | CN | disclosed |
| EP-3241829-B1 | HETEROARYLPIPERIDINE AND -PIPERAZINE DERIVATIVES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2020-12-23 | — | — | EP | disclosed |
| EP-3474986-A1 | GAS CAPTURE USING POLYMERIC PARTICLES | Charmstar Cambridge Limited (GB) | 2019-05-01 | — | — | EP | disclosed |
| EP-2609094-B1 | HETEROARYLPIPERIDINE AND -PIPERAZINE DERIVATIVES AS FUNGICIDES | BAYER IP GMBH (DE) | 2018-05-30 | — | — | EP | disclosed |
| US-9930890-B2 | Heteroarylpiperidine and -piperazine derivatives as fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2018-04-03 | — | — | US | disclosed |
| US-20180007903-A1 | Heteroarylpiperidine and -piperazine derivatives as fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2018-01-11 | — | — | US | disclosed |
| EP-3252087-A1 | COMPOSITION FOR FORMING EASY-TO-DETACH THIN RESIN FILM, AND EASY-TO-DETACH THIN RESIN FILM | Nissan Chemical Industries, Ltd. (JP) | 2017-12-06 | — | — | EP | disclosed |
| EP-3241829-A1 | HETEROARYLPIPERIDINE AND -PIPERAZINE DERIVATIVES AS FUNGICIDES | Bayer Intellectual Property GmbH (DE) | 2017-11-08 | — | — | EP | disclosed |
| US-20080188528-A1 | Modulators of C3a receptor and methods of use thereof | ENCYSIVE PHARMACEUTICALS, INC. | 2008-08-07 | — | — | US | disclosed |
| WO-2008079371-A1 | MODULATORS OF C3A RECEPTOR AND METHODS OF USE THEREOF | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2008-07-03 | — | — | WO | disclosed |
| US-20080081897-A1 | Solvent resistant high performance liquid chromatography material; ethenically unsaturated functionalized polysaccharide copolymerized with free radical monomer and chemically bound to silica gel matrix; short step synthesis | DAICEL CHEMICAL INDUSTRIES, LTD. | 2008-04-03 | — | — | US | disclosed |
| US-7323101-B2 | Separating agent for optical isomer and method for preparation thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2008-01-29 | — | — | US | disclosed |
| EP-1498404-B1 | SEPARATING AGENT FOR OPTICAL ISOMER AND METHOD FOR PREPARATION THEREOF | DAICEL CHEM (JP) | 2007-08-08 | — | — | EP | disclosed |
| US-20060134062-A1 | Polymeric boronic acid derivatives as lipase inhibitors | GENZYME CORPORATION | 2006-06-22 | — | — | US | disclosed |
| US-20050222454-A1 | Separating agent for optical isomer and method for preparation thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2005-10-06 | — | — | US | disclosed |
| EP-1578816-A1 | POLYMERIC BORONIC ACID DERIVATIVES AS LIPASE INHIBITORS | Genzyme Corporation (US) | 2005-09-28 | — | — | EP | disclosed |
| EP-1498404-A1 | SEPARATING AGENT FOR OPTICAL ISOMER AND METHOD FOR PREPARATION THEREOF | Daicel Chemical Industries, Ltd. (JP) | 2005-01-19 | — | — | EP | disclosed |
| WO-2004046211-A1 | POLYMERIC BORONIC ACID DERIVATIVES AS LIPASE INHIBITORS | GENZYME CORPORATION (US) | 2004-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060134062-A1 | Polymeric boronic acid derivatives as lipase inhibitors | CEL, LIPE, LPL | ALDH1A1 378/4885TGM2 1293/4885MAOB 78/4885 |
| US-20080188528-A1 | Modulators of C3a receptor and methods of use thereof | C3AR1, C5, C5AR1 | ALDH1A1 1639/4885TGM2 4186/4885MAOB 550/4885 |
| US-20180007903-A1 | Heteroarylpiperidine and -piperazine derivatives as fungicides | CYP1A1, PRXL2A, CYP1A2 | ALDH1A1 1292/4885TGM2 2252/4885MAOB 511/4885 |
| US-20050222454-A1 | Separating agent for optical isomer and method for preparation thereof | GNE, DDOST, GALE | ALDH1A1 1806/4885TGM2 3031/4885MAOB 2488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.